Search

Ernesto Arturio Grano

Examiner (ID: 19022)

Most Active Art Unit
3735
Art Unit(s)
3728, 3788, 3735, 4147
Total Applications
1168
Issued Applications
657
Pending Applications
77
Abandoned Applications
448

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19947145 [patent_doc_number] => 12318483 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-06-03 [patent_title] => Manufacturing of bupivacaine multivesicular liposomes [patent_app_type] => utility [patent_app_number] => 18/957404 [patent_app_country] => US [patent_app_date] => 2024-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 24346 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18957404 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/957404
Manufacturing of bupivacaine multivesicular liposomes Nov 21, 2024 Issued
Array ( [id] => 19815136 [patent_doc_number] => 20250073343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => PROTEIN-LOADED PLGA NANOSPHERES [patent_app_type] => utility [patent_app_number] => 18/952404 [patent_app_country] => US [patent_app_date] => 2024-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18952404 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/952404
PROTEIN-LOADED PLGA NANOSPHERES Nov 18, 2024 Pending
Array ( [id] => 19799024 [patent_doc_number] => 20250064949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => PROTEIN-LOADED PLGA NANOSPHERES [patent_app_type] => utility [patent_app_number] => 18/946447 [patent_app_country] => US [patent_app_date] => 2024-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18946447 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/946447
PROTEIN-LOADED PLGA NANOSPHERES Nov 12, 2024 Pending
Array ( [id] => 20006015 [patent_doc_number] => 20250144237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM [patent_app_type] => utility [patent_app_number] => 18/939439 [patent_app_country] => US [patent_app_date] => 2024-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7283 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18939439 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/939439
AGENTS, COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF NUCLEIC ACIDS TO THE CELLS WITHIN THE RESPIRATORY SYSTEM Nov 5, 2024 Pending
Array ( [id] => 20212472 [patent_doc_number] => 12409106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Medical material [patent_app_type] => utility [patent_app_number] => 18/922818 [patent_app_country] => US [patent_app_date] => 2024-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 12483 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18922818 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/922818
Medical material Oct 21, 2024 Issued
Array ( [id] => 19768300 [patent_doc_number] => 20250049726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => MANGANESE-DOPED HOLLOW MESOPOROUS SILICA NANOPARTICLES LOADED WITH CURCUMIN [patent_app_type] => utility [patent_app_number] => 18/762795 [patent_app_country] => US [patent_app_date] => 2024-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762795 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/762795
Manganese-doped hollow mesoporous silica nanoparticles loaded with curcumin Jul 2, 2024 Issued
Array ( [id] => 19608081 [patent_doc_number] => 12156940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-03 [patent_title] => Manufacturing of bupivacaine multivesicular liposomes [patent_app_type] => utility [patent_app_number] => 18/761863 [patent_app_country] => US [patent_app_date] => 2024-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 28444 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761863 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/761863
Manufacturing of bupivacaine multivesicular liposomes Jul 1, 2024 Issued
Array ( [id] => 19830789 [patent_doc_number] => 20250082575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => GAMMA POLYGLUTAMATED PRALATREXATE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/745801 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73486 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745801 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745801
GAMMA POLYGLUTAMATED PRALATREXATE AND USES THEREOF Jun 16, 2024 Pending
Array ( [id] => 19830853 [patent_doc_number] => 20250082639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/745749 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745749 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/745749
ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF Jun 16, 2024 Pending
Array ( [id] => 19541670 [patent_doc_number] => 20240358706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin [patent_app_type] => utility [patent_app_number] => 18/676591 [patent_app_country] => US [patent_app_date] => 2024-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18676591 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/676591
Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin May 28, 2024 Abandoned
Array ( [id] => 19682252 [patent_doc_number] => 20250000797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => NANOMATERIALS [patent_app_type] => utility [patent_app_number] => 18/673962 [patent_app_country] => US [patent_app_date] => 2024-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18673962 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/673962
NANOMATERIALS May 23, 2024 Pending
Array ( [id] => 19570217 [patent_doc_number] => 20240374509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => VIRUS [patent_app_type] => utility [patent_app_number] => 18/662148 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662148 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662148
VIRUS May 12, 2024 Pending
Array ( [id] => 19526774 [patent_doc_number] => 20240350676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO [patent_app_type] => utility [patent_app_number] => 18/660467 [patent_app_country] => US [patent_app_date] => 2024-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660467 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/660467
COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO May 9, 2024 Pending
Array ( [id] => 19447154 [patent_doc_number] => 20240307284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => EMULSION COMPOSITION AND PRODUCTION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/658553 [patent_app_country] => US [patent_app_date] => 2024-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18658553 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/658553
EMULSION COMPOSITION AND PRODUCTION METHOD THEREOF May 7, 2024 Pending
Array ( [id] => 19402058 [patent_doc_number] => 20240285569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => METHODS FOR DECREASING INJURIES ASSOCIATED WITH INTRAOPERATIVE HYPOTENSION [patent_app_type] => utility [patent_app_number] => 18/651154 [patent_app_country] => US [patent_app_date] => 2024-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18651154 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/651154
Methods for decreasing injuries associated with intraoperative hypotension Apr 29, 2024 Issued
Array ( [id] => 19541709 [patent_doc_number] => 20240358745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => COMPOSITIONS AND METHODS OF DISSOLVING BIOFILM TO PROMOTE WOUND HEALING [patent_app_type] => utility [patent_app_number] => 18/649065 [patent_app_country] => US [patent_app_date] => 2024-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649065 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/649065
COMPOSITIONS AND METHODS OF DISSOLVING BIOFILM TO PROMOTE WOUND HEALING Apr 28, 2024 Pending
Array ( [id] => 19762197 [patent_doc_number] => 12220468 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-02-11 [patent_title] => Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis [patent_app_type] => utility [patent_app_number] => 18/636721 [patent_app_country] => US [patent_app_date] => 2024-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6985 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18636721 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/636721
Atomic scale topical composition with enhanced interstitial cellular uptake for increased moisturizing, fluidity, antioxidant and radiation protection, antimicrobial cleansing and therapeutics for optimal dermal integrity and homeostasis Apr 15, 2024 Issued
Array ( [id] => 19496509 [patent_doc_number] => 20240335527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/629296 [patent_app_country] => US [patent_app_date] => 2024-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629296 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/629296
VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME Apr 7, 2024 Pending
Array ( [id] => 19297525 [patent_doc_number] => 20240226090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan [patent_app_type] => utility [patent_app_number] => 18/613609 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17056 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613609 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/613609
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan Mar 21, 2024 Abandoned
Array ( [id] => 19570229 [patent_doc_number] => 20240374521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => RIBOSE CATIONIC LIPIDS [patent_app_type] => utility [patent_app_number] => 18/609160 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609160 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/609160
RIBOSE CATIONIC LIPIDS Mar 18, 2024 Pending
Menu